Literature DB >> 32750103

Dosing-related saturation of toxicity and accelerated drug clearance with pegaspargase treatment.

Yiwei Liu1, John C Panetta1, Wenjian Yang1, Seth E Karol2, Cheng Cheng3, Jun J Yang1, William E Evans1, Hiroto Inaba2, Ching-Hon Pui2, Sima Jeha2, Mary V Relling1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32750103      PMCID： PMC7751363          DOI： 10.1182/blood.2020006214

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.

Authors:  Tatsuhiro Ishida; Hiroshi Kiwada
Journal:  Int J Pharm       Date:  2007-11-09       Impact factor: 5.875

2.  Individualized Asparaginase Dosing in Childhood Acute Lymphoblastic Leukemia.

Authors:  Robin Q H Kloos; Rob Pieters; Florine M V Jumelet; Hester A de Groot-Kruseman; Cor van den Bos; Inge M van der Sluis
Journal:  J Clin Oncol       Date:  2020-01-10       Impact factor: 44.544

3.  Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy.

Authors:  Y Liu; C A Fernandez; C Smith; W Yang; C Cheng; J C Panetta; N Kornegay; C Liu; L B Ramsey; S E Karol; L J Janke; E C Larsen; N Winick; W L Carroll; M L Loh; E A Raetz; S P Hunger; M Devidas; J J Yang; C G Mullighan; J Zhang; W E Evans; S Jeha; C-H Pui; M V Relling
Journal:  Clin Pharmacol Ther       Date:  2017-04-04       Impact factor: 6.875

4.  Antibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge.

Authors:  Yiwei Liu; Colton A Smith; John C Panetta; Wenjian Yang; Lauren E Thompson; Jacob P Counts; Alejandro R Molinelli; Deqing Pei; Nancy M Kornegay; Kristine R Crews; Hope Swanson; Cheng Cheng; Seth E Karol; William E Evans; Hiroto Inaba; Ching-Hon Pui; Sima Jeha; Mary V Relling
Journal:  J Clin Oncol       Date:  2019-06-12       Impact factor: 44.544

5.  Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols.

Authors:  H J Müller; L Löning; A Horn; D Schwabe; M Gunkel; M Schrappe; V von Schütz; G Henze; J Casimiro da Palma; J Ritter; J P Pinheiro; M Winkelhorst; J Boos
Journal:  Br J Haematol       Date:  2000-08       Impact factor: 6.998

6.  A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study.

Authors:  Vassilios I Avramis; Susan Sencer; Antonia P Periclou; Harland Sather; Bruce C Bostrom; Lewis J Cohen; Alice G Ettinger; Lawrence J Ettinger; Janet Franklin; Paul S Gaynon; Joanne M Hilden; Beverly Lange; Fataneh Majlessipour; Pracad Mathew; Michael Needle; Joseph Neglia; Gregory Reaman; John S Holcenberg; Linda Stork
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

7.  A population pharmacokinetic model for pegylated-asparaginase in children.

Authors:  Georg Hempel; Hans-Joachim Müller; Claudia Lanvers-Kaminsky; Gudrun Würthwein; Antje Hoppe; Joachim Boos
Journal:  Br J Haematol       Date:  2009-10-11       Impact factor: 6.998

8.  Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients.

Authors:  Jonathan K Armstrong; Georg Hempel; Susanne Koling; Linda S Chan; Timothy Fisher; Herbert J Meiselman; George Garratty
Journal:  Cancer       Date:  2007-07-01       Impact factor: 6.860

Review 9.  The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.

Authors:  Amr S Abu Lila; Hiroshi Kiwada; Tatsuhiro Ishida
Journal:  J Control Release       Date:  2013-08-07       Impact factor: 9.776

10.  Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16.

Authors:  Sima Jeha; Deqing Pei; John Choi; Cheng Cheng; John T Sandlund; Elaine Coustan-Smith; Dario Campana; Hiroto Inaba; Jeffrey E Rubnitz; Raul C Ribeiro; Tanja A Gruber; Susana C Raimondi; Raja B Khan; Jun J Yang; Charles G Mullighan; James R Downing; William E Evans; Mary V Relling; Ching-Hon Pui
Journal:  J Clin Oncol       Date:  2019-10-28       Impact factor: 44.544
  10 in total
  1 in total

1.  Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase.

Authors:  John C Panetta; Yiwei Liu; Teodoro Bottiglieri; Erland Arning; Cheng Cheng; Seth E Karol; Jun J Yang; Yinmei Zhou; Hiroto Inaba; Ching-Hon Pui; Sima Jeha; Mary V Relling
Journal:  Cancer Chemother Pharmacol       Date:  2021-06-25       Impact factor: 3.288
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.